and Validation of New Interleukin‑2
Ligands Using DNA-Encoded Libraries
Posted on 25.11.2021 - 16:33
Interleukin-2 (IL2) is a pro-inflammatory cytokine that plays a crucial role in immunity, which is increasingly being used for therapeutic applications. There is growing interest in developing IL2-based therapeutics which do not interact with the alpha subunit of the IL2 receptor (CD25) as this protein is primarily found on immunosuppressive regulatory T cells (Tregs). Screenings of a new DNA-encoded library, comprising 669,240 members, provided a novel series of IL2 ligands, subsequently optimized by medicinal chemistry. One of these molecules (compound 18) bound to IL2 with a dissociation constant of 0.34 μM was able to form a kinetically stable complex with IL2 in size-exclusion chromatography and recognized the CD25-binding site as evidenced by competition experiments with the NARA1 antibody. Compound 18 and other members of the series may represent the starting point for the discovery of potent small-molecule modulators of IL2 activity, abrogating the binding to CD25.
CITE THIS COLLECTION
Gironda-Martínez, Adrián; Gorre, Émile M. D.; Prati, Luca; Gosalbes, Jean-François; Dakhel, Sheila; Cazzamalli, Samuele; et al. (2021): Identification and Validation of New Interleukin‑2 Ligands Using DNA-Encoded Libraries. ACS Publications. Collection. https://doi.org/10.1021/acs.jmedchem.1c01693
Select your citation style and then place your mouse over the citation text to select it.
Read the peer-reviewed publication
Émile M. D. Gorre
Etienne J. Donckele
kinetically stable complexseries may representencoded libraries interleukin18 </ bnovel seriesencoded librarytherapeutic applicationssubsequently optimizedstarting pointprimarily foundpotent smallnew dnanara1 antibodymolecule modulatorsmedicinal chemistryinflammatory cytokineimmunosuppressive regulatorygrowing interestexclusion chromatographydissociation constantcrucial rolecomprising 669competition experimentsbased therapeuticsalpha subunit34 μm